Budd-Chiari syndrome

Seminars in Liver Disease

Volumn 28, Issue 3, 2008, Pages 259-269

  Plessier, Aurélie ^a   Valla, Dominique Charles ^a,b  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Angioplasty; Anticoagulation; Liver transplantation; Myeloproliferative disease; Thrombophilia; Thrombosis; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYUREA; JANUS KINASE 2; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT;

ANTICOAGULATION; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BUDD CHIARI SYNDROME; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DOPPLER ECHOGRAPHY; DRUG FATALITY; ECHO PLANAR IMAGING; ELECTRON SPIN RESONANCE; GENE MUTATION; GRANULOCYTE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPATIC VEIN; HUMAN; INFERIOR CAVA VEIN; INTERNATIONAL NORMALIZED RATIO; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER VEIN OBSTRUCTION; LOW DRUG DOSE; LUNG EMBOLISM; MESOCAVAL SHUNT; MYELOPROLIFERATIVE DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHLEBOGRAPHY; PORTAL HYPERTENSION; PORTAL PHLEBOGRAPHY; PORTOCAVAL SHUNT; PORTOSYSTEMIC ANASTOMOSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; REVIEW; RISK FACTOR; STENT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOSIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VEIN LIGATION; VEIN OCCLUSION; VEIN THROMBOSIS;

ANGIOPLASTY; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; BUDD-CHIARI SYNDROME; CHILD; HEPATIC VEINS; HUMANS; HYPERTENSION, PORTAL; LIVER TRANSPLANTATION; PORTAL VEIN; PORTASYSTEMIC SHUNT, SURGICAL; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; STENTS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 52949110579     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0028-1085094     Document Type: Review

References (138)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364-371
2. de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43(1):167-176
3. Ludwig J, Hashimoto E, McGill D, Heerden JV. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 1990;65:51-55
4. Shrestha SM, Okuda K, Uchida T, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 1996;11:170-179
5. Valla D. Hepatic venous outflow tract obstruction etipathogenesis: Asia versus the West. J Gastroenterol Hepatol 2004;19:S204-S211
6. Darwish-Murad S, Plessier A, Hernandez-Guerra M, et al. A prospective study on 163 pattients with Budd-Chiari syndrome: results from the European Network for Vascular Disorders of the Liver (EN-VIE). J Hepatol 2007;46:S4
7. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis 2002;22:5-14
8. Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 2002;22:15-26
9. Mehrotra G, Singh RP, Krishna A, Singh BK. Pyogenic liver abscess causing acute Budd-Chiari syndrome. Ann Trop Paediatr 1992;12:451-453
10. Uddin W, Ramage JK, Portmann B, et al. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment. Gut 1995;36:142-145
11. Rangheard AS, Vilgrain V, Audet P, et al. Focal nodular hyperplasia inducing hepatic vein obstruction. AJR Am J Roentgenol 2002;179:759-762
12. Kubo T, Shibata T, Itoh K, et al. Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology 2006;239:285-290
13. Wang SL, Sze DY, Busque S, et al. Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. Radiology 2005;236:352-359
14. Balian A, Valla D, Naveau S, et al. Post-traumatic membranous obstruction of the inferior vena cava associated with a hypercoagulable state. J Hepatol 1998;28:723-726
15. Markert DJ, Shanmuganathan K, Mirvis SE, Nakajima Y, Hayakawa M. Budd-Chiari syndrome resulting from intrahepatic IVC compression secondary to blunt hepatic trauma. Clin Radiol 1997;52:384-387
16. Kim PN, Mitchell DG, Outwater EK. Budd-Chiari syndrome: hepatic venous obstruction by an elevated diaphragm. Abdom Imaging 1999;24:267-271
17. Hirshberg B, Shouval D, Fibach E, Friedman G, Ben-Yehuda D. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol 2000;32:574-578
18. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-2368
19. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology 2001; 34:666-670
20. Deltenre P, Denninger MH, Hillaire S, et al. Factor V Leiden related Budd-Chiari syndrome. Gut 2001;48:264-268
21. Lin GL, Xu PQ, Qi H, Lian JH, Zheng H, Dang XW. Relations of Budd-Chiari syndrome to prothrombin gene mutation. Hepatobiliary Pancreat Dis Int 2004;3:214-218
22. Kumar SI, Kumar A, Srivastava S, Saraswat VA, Aggarwal R. Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. Indian J Gastroenterol 2005;24:211-215
23. Colak Y, Karasu Z, Oruc N, et al. Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol 2006;18: 917-920
24. Li XM, Wei YF, Hao HL, et al. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol 2002;71:11-14
25. Dayal S, Pati HP, Pande GK, Sharma MP, Saraya AK. Multilineage hemopoietic stem cell defects in Budd-Chiari syndrome. J Hepatol 1997;26:293-297
26. Bayraktar Y, Balkanci F, Kansu E, et al. Cavernous transformation of the portal vein: a common manifestation of Behcet's disease. Am J Gastroenterol 1995;90:1476-1479
27. Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006;130:2031-2038
28. Primignani M, Barosi G, Bergamaschi G, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006;44:1528-1534
29. Kiladjian JJ, Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases. Blood 2008;111(10):4835-4836
30. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet's disease. Am J Gastroenterol 1997;92:858-862
31. Zylberberg H, Valla D, Viguie F, Casadevall N. Budd-Chiari syndrome associated with 5q deletion and hypereosinophilia. J Clin Gastroenterol 1996;23:66-68
32. Young ID, Clark RN, Manley PN, Groll A, Simon JB. Response to steroids in Budd-Chiari syndrome caused by idiopathic granulomatous venulitis. Gastroenterology 1988; 94:503-507
33. Rahhal RM, Pashankar DS, Bishop WP. Ulcerative colitis complicated by ischemic colitis and Budd-Chiari syndrome. J Pediatr Gastroenterol Nutr 2005;40:94-97
34. Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994;73:21-36
35. Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 1980;68:113-121
36. Rautou PE, Angermayr B, Raffa S, et al. Maternal and fetal outcome in 27 women with Budd-Chiari syndrome and 41 pregnancies. Hepatology 2007;46:563A
37. Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou JP. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology 1986;90:807-811
38. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-591
39. Parker RGF. Occlusion of the hepatic veins in man. Medicine (Baltimore) 1959;38:369-402
40. Hadengue A, Poliquin M, Vilgrain V, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994;106:1042-1047
41. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998;27:488-496
42. Cazals-Hatem D, Vilgrain V, Genin P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology 2003; 37:510-519
43. Mahmoud AEA, Helmy AS, Billingham S, Elias E. Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol 1997;9:485-489
44. Tavill AS, Wood EJ, Kreel L, Jones EA, Gregory M, Sherlock S. The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology 1975;68: 509-518
45. Miller WJ, Federle MP, Straub WH, Davis PL. Budd-Chiari syndrome: imaging with pathologic correlation. Abdom Imaging 1993;18:329-335
46. Millener P, Grant EG, Rose S, et al. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. AJR Am J Roent-genol 1993;161:307-312
47. Chawla Y, Kumar S, Dhiman RK, Suri S, Dilawari JB. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol 1999;14:904-907
48. Grant EG, Perrella R, Tessler FN, Lois J, Busuttil R. Budd-Chiari syndrome: the results of duplex and color Doppler imaging. AJR Am J Roentgenol 1989;152:377-381
49. Kane R, Eustace S. Diagnosis of Budd-Chiari syndrome: comparison between sonography and MR angiography. Radiology 1995;195:117-121
50. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002;22:27-42
51. Rector WG, Xu YH, Goldstein L, Peters RL, Reynolds TB. Membranous obstruction of the inferior vena cava in the United States. Medicine (Baltimore) 1985;64:134-143
52. Gupta S, Barter S, Phillips GW, Gibson RN, Hodgson HJ. Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome. Gut 1987;28:242-247
53. Mathieu D, Kracht M, Zafrani E, Dhumeaux D, Vasile N. Budd-Chiari syndrome. Ferrucci J, Matthieu D, eds. Advances in Hepatobiliairy Radiology. St Louis: C.V. Mosby Company; 1990:3-28
54. Menu Y, Alison D, Lorphelin JM, Valla D, Belghiti J, Nahum H. Budd-Chiari syndrome: US evaluation. Radiology 1985;157:761-764
55. Baert AL, Fevery J, Marchal G, et al. Early diagnosis of Budd-Chiari syndrome by computed tomography and ultrasonography: report of five cases. Gastroenterology 1983;84:587-595
56. Van Beers B, Pringot J, Trigaux JP, Dautrebande J, Mathurin P. Hepatic heterogeneity on CT in Budd-Chiari syndrome: correlation with regional disturbances in portal flow. Gastrointest Radiol 1988;13:61-66
57. Solano FX, Young E, Talamo TS, Dekker A. Constrictive pericarditis mimicking Budd-Chiari syndrome. Am J Med 1986;80:113-115
58. Shin SH, Chung YH, Suh DD, et al. Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2004;16:319-324
59. Havlioglu N, Brunt EM, Bacon BR. Budd-Chiari syndrome and hepatocellular carcinoma: a case report and review of the literature. Am J Gastroenterol 2003;98:201-204
60. Moucari R, Rautou PE, Cazals-Hatem D, et al. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 2008;57(6):828-835
61. Vons C, Smadja C, Franco D, Valla D, Rueff B, Benhamou JP. Successful pregnancy after Budd-Chiari syndrome. Lancet 1984;2:975
62. Landolfi R, Marchioli R, Kutti J, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 2004; 350:114-124
63. De Ledinghen V, Heresbach D, Fourdan O, et al. Antiinflammatory drugs and variceal bleeding: a case-control study. Gut 1999;44:270-273
64. Bates SM, Ginsberg JS. Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med 2004;351:268-277
65. Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30:84-89
66. Murad SD, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39:500-508
67. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44:1308-1316
68. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006; 55:878-884
69. Campbell DA, Rolles K, Jamieson N, et al. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet 1988;166:511-518
70. Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990;211:43-49
71. Zhang CQ, Fu LN, Xu L, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol 2003;9:2587-2591
72. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44(5):1308-1316
73. Barrault C, Plessier A, Valla D, Condat B. Non surgical treatment of Budd-Chiari syndrome: a review. Gastroenterol Clin Biol 2004;28:40-49
74. Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP. Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol 2004;40:172-180
75. Hernandez-Guerra M, Lopez E, Bellot P, et al. Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome. Hepatology 2006;43:27-33
76. Valla D, Hadengue A, el Younsi M, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology 1997;25:814-819
77. Griffith JF, Mahmoud AE, Cooper S, Elias E, West RJ, Olliff SP. Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol 1996;51:775-784
78. Martin LG, Henderson JM, Millikan WJ, Casarella WJ, Kaufman SL. Angioplasty for long-term treatment of patients with Budd-Chiari syndrome. AJR Am J Roentgenol 1990;154:1007-1010
79. Nunez O, de la Cruz G, Molina J, et al. Interventional radiology, angioplasty and TIPS in Budd-Chiari syndrome. Gastroenterol Hepatol 2003;26:461-464
80. Pelage JP, Denys A, Valla D, et al. Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur Radiol 2003;13:286-293
81. Witte AM, Kool LJ, Veenendaal R, Lamers CB, van Hoek B. Hepatic vein stenting for Budd-Chiari syndrome. Am J Gastroenterol 1997;92:498-501
82. Qiao T, Liu CJ, Liu C, Chen K, Zhang XB, Zu MH. Interventional endovascular treatment for Budd-Chiari syndrome with long-term follow-up. Swiss Med Wkly 2005;135:318-326
83. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Kobayashi N. Segmental obstruction of the hepatic inferior vena cava treated by transluminal angioplasty. Radiology 1983;149:91-96
84. Guan H. [Diagnosis and treatment of membraneous obstruction of the inferior vena cava]. Zhonghua Wai Ke Za Zhi 1990;28:760-763783-764
85. Sato M, Yamada R, Tsuji K, et al. Percutaneous transluminal angioplasty in segmental obstruction of the hepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol 1990;13:189-192
86. Kohli V, Pande GK, Dev V, Reddy KS, Kaul U, Nundy S. Management of hepatic venous outflow obstruction. Lancet 1993;342:718-722
87. Yang XL, Cheng TO, Chen CR. Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. J Am Coll Cardiol 1996;28:1720-1724
88. Tyagi S, Jain BL, Kumar N, Lahoti D, Arora R. Balloon dilatation of inferior vena cava stenosis in Budd-Chiari syndrome. J Assoc Physicians India 1996;44:378-380
89. Bilbao JI, Pueyo JC, Longo JM, et al. Interventional therapeutic techniques in Budd-Chiari syndrome. Cardiovasc Intervent Radiol 1997;20:112-119
90. De BK, Biswas PK, Sen S, et al. Management of the Budd-Chiari syndrome by balloon cavoplasty. Indian J Gastroenterol 2001;20:151-154
91. Wu T, Wang L, Xiao Q, et al. Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. Int J Cardiol 2002;83:175-178
92. Mishra TK, Routray SN, Behera M, Patnaik UK, Satapathy C. Percutaneous balloon angioplasty of membranous obstruction of the inferior vena cava. Indian Heart J 2003; 55:362-364
93. Xu K, Feng B, Zhong H, et al. Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. Chin Med J (Engl) 2003;116:609-615
94. Xiaoming Z, Zhonggao W. Interventional or semi-inter-ventional treatment for Budd-Chiari syndrome. Chin Med Sci J 2003;18:111-115
95. Khuroo MS, Al-Suhabani H, Al-Sebayel M, et al. Budd-Chiari syndrome: long-term effect on outcome with trans-jugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2005;20:1494-1502
96. Lee BB, Villavicencio L, Kim YW, et al. Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. J Vasc Surg 2006;43:101-108
97. Furui S, Sawada S, Irie T, et al. Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents. Radiology 1990;176:665-670
98. Langlet P, Valla D. Is surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome? Acta Gastroenterol Belg 2002;65:155-160
99. Panis Y, Belghiti J, Valla D, Benhamou JP, Fekete F. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery 1994;115:276-281
100. Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg 1996;171:176-180; discussion 180-171
101. Tang TJ, Batts KP, de Groen PC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 2001;35:338-343
102. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003;39:496-501
103. Bachet JB, Condat B, Hagege H, et al. Long term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol 2007;46(1):60-68
104. Feng LS, Peng QP, Li K, et al. Management of severe Budd-Chiari syndrome: report of 147 cases. Hepatobiliary Pancreat Dis Int 2004;3:522-525
105. Savader SJ, Venbrux AC, Klein AS, Osterman FA. Percutaneous intervention in portosystemic shunts in Budd-Chiari syndrome. J Vasc Interv Radiol 1991;2:489-495
106. Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg 2000;232:340-352
107. Bismuth H, Sherlock DJ. Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 1991;214:581-589
108. Orloff LA, Orloff MJ. Budd-Chiari syndrome caused by Behcet's disease: treatment by side-to-side portacaval shunt. J Am Coll Surg 1999;188:396-407
109. Ganger DR, Klapman JB, McDonald V, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol 1999;94:603-608
110. Ryu RK, Durham JD, Krysl J, et al. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol 1999;10:799-805
111. Slakey DP, Klein AS, Venbrux AC, Cameron JL. Budd-Chiari syndrome: current management options. Ann Surg 2001;233:522-527
112. Cejna M, Peck-Radosavljevic M, Schoder M, et al. Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome. J Vasc Interv Radiol 2002;13:193-199
113. Perello A, Garcia-Pagan JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002;35:132-139
114. Blokzijl H, de Knegt RJ. Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt. Hepatology 2002;35:1551-1552
115. Mancuso A, Fung K, Mela M, et al. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. J Hepatol 2003;38:751-754
116. Kavanagh PM, Roberts J, Gibney R, Malone D, Hegarty J, McCormick PA. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2004;19:1135-1139
117. Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther 2004;20:867-873
118. Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004;135:394-403
119. Safka V, Hulek P, Krajina A, et al. Budd-Chiari syndrome and TIPS-twelve years' experience. Cas Lek Cesk 2005; 144(Suppl 3):38-42
120. Molmenti EP, Segev DL, Arepally A, et al. The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg 2005;241:978-981; discussion 982-973
121. Hernandez-Guerra M, Turnes J, Rubinstein P, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004;40:1197-1202
122. Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006;44:520-528
123. Shaked A, Goldstein RM, Klintmalm GB, Drazan K, Husberg B, Busuttil RW. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992;174:453-459
124. Ringe B, Lang H, Oldhafer KJ, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 1995;21:1337-1344
125. Henderson JM, Warren WD, Millikan WJ, et al. Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome. Am J Surg 1990;159:41-48; discussion 48-50
126. Malkowski P, Michalowicz B, Pawlak J, et al. Surgical and interventional radiological treatment of Budd-Chiari syndrome: report of nine cases. Hepatogastroenterology 2003;50: 2049-2051
127. Jamieson NV, Williams R, Calne RY. Liver transplantation for Budd-Chiari syndrome, 1976-1990. Ann Chir 1991;45: 362-365
128. Srinivasan P, Rela M, Prachalias A, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation 2002; 73:973-977
129. Segev DL, Nguyen GC, Locke JE, et al. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl 2007;13:1285-1294
130. Melear JM, Goldstein RM, Levy MF, et al. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation 2002;74:1090-1095
131. Valla DC. Prognosis in Budd Chiari syndrome after reestablishing hepatic venous drainage. Gut 2006;55:761-763
132. Min AD, Atillasoy EO, Schwartz ME, Thiim M, Miller CM, Bodenheimer HC. Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg 1997;3:423-429
133. Murad SD, Valla DC, de Groen PC, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006;101:83-90
134. Chait Y, Condat B, Cazals-Hatem D, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol 2005;129:553-560
135. Gentil-Kocher S, Bernard O, Brunelle F, et al. Budd-Chiari syndrome in children: report of 22 cases. J Pediatr 1988;113: 30-38
136. Boudhina T, Ghram N, Ben Becher S, et al. Budd-Chiari syndrome in children. Apropos of 7 cases. Arch Fr Pediatr 1991;48:243-248
137. Odell JA, Rode H, Millar AJ, Hoffman HD. Surgical repair in children with the Budd-Chiari syndrome. J Thorac Cardiovasc Surg 1995;110:916-923
138. Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006;23: 767-775